Search

Home > The Elective Rotation: A Critical Care Hospital Pharmacy Podcast > 731: Company sponsored indrect comparison concludes the company’s product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage
Podcast: The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
Episode:

731: Company sponsored indrect comparison concludes the company’s product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage
Category: Science & Medicine
Duration: 00:04:10
Publish Date: 2022-07-18 07:00:05
Description:

Show notes at pharmacyjoe.com/episode731.

In this episode, I ll discuss a company-sponsored indirect comparative study looking at andexanet alfa vs 4 factor prothrombin complex concentrate (4FPCC) for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage.

The post 731: Company sponsored indrect comparison concludes the company’s product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage appeared first on Pharmacy Joe.
Total Play: 0